Caroline Corner | Investor Relations |
Joshua Riggs | President and Chief Executive Officer |
Anish John | Chief Financial Officer |
Mark Massaro | BTIG |
Mason Carrico | Stephens Inc |
Bruce Jackson | The Benchmark Company |
David Westenberg | Piper Sandler |
Good day and welcome to the OncoCyte Conference Call to discuss the Fourth Quarter and Year End 2022 Financial Results. Today’s call is being recorded. At this time, I’d like to turn the call over to Caroline Corner, Westwicke Investor Relations. Please go ahead.
Thank you everyone for joining us for today’s conference call to discuss OncoCyte’s fourth quarter and year end 2022 financial results and recent operating highlights.